Global prosthetic heart valve market set to more than double by 2033

The prosthetic heart valve market is on track to grow from USD 9.64 billion in 2024 to USD 20.69 billion by 2033, driven by rising cases of valvular heart disease and an ageing global population. With a CAGR of 8.7%, demand for both surgical and transcatheter valve replacements is accelerating.

North America leads the market with nearly half of global revenue in 2024, while Asia Pacific is poised for the fastest growth. Transcatheter valves and biological tissue materials dominate in terms of valve type and composition, with hospitals representing the largest end-user group.

Rheumatic heart disease, calcific aortic valve disease, and degenerative mitral valve disorders affect over 80 million people globally — creating sustained demand for advanced valve replacement solutions.

Read the full article here to explore what’s driving this life-saving market forward.